YVONNE RUIZ: Open Payments
NPI 1659951770 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$680 in 28 payments from 10 companies in 2025. Trend: 2023 $153 · 2024 $590 · 2025 $680
Food & beverage: $680
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $185 |
| AstraZeneca Pharmaceuticals LP | 6 | $142 |
| PFIZER INC. | 1 | $125 |
| Novo Nordisk Inc | 2 | $48 |
| Dexcom, Inc. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Amgen Inc. | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
Products named: ZEPBOUND, NURTEC ODT, FARXIGA, MOUNJARO, Dexcom G6 Transmitter, TRELEGY ELLIPTA, BREZTRI, Ozempic.
Industry payments across TX — which companies pay providers there.
